Celgene, one of biopharma’s most aggressive and creative dealmakers, said Thursday it has forged a deep partnership with South San Francisco, CA-based Sutro Biopharma that could end up with an acquisition.
If it does, it would dramatically expand Celgene’s footprint into... Read more »
People have been cross-breeding their food for thousands of years—but modifying food in a lab is still relatively new and has ignited serious controversy.
We recently talked with New York Times science reporter Amy Harmon and genetics professor Pamela Ronald about the... Read more »
Here’s a quick rundown of recent news from Wisconsin’s technology and innovation community:
—Madison-based Deltanoid Pharmaceuticals announced top-line data from a Phase 2b clinical trial of its vitamin D-based drug, DP001, as a treatment for a hormonal imbalance that can occur... Read more »
The high cost of batteries has made them impractical for storing energy from wind and solar or providing back-up power on the electricity grid. Now, though, several battery startups are claiming price reductions that make energy storage on the grid look... Read more »
According to data released last week by the National Venture Capital Association (NVCA), the third quarter of 2014 was a busy one in the state of Michigan.
The NVCA’s report, based on information collected by Pricewaterhouse Coopers and Thomson Reuters, says... Read more »
Young Houston biotech companies will, by late next year, have a new partner in Johnson & Johnson.
The pharmaceutical giant said today that that it will house one of its J-Labs, formerly known as Janssen Labs, at the Texas Medical Center... Read more »
It’s notoriously difficult to develop drugs for pain, in part because the results from animal tests rarely hold up in human studies. Still, a new startup from Atlas Venture called Quartet Medicine will to try to navigate the minefield, buoyed by... Read more »
Advocates of cleantech investing often make the case that there are enormous opportunities to make the world cleaner and more sustainable. But what if labeling yourself a cleantech investor or entrepreneur is actually limiting?
That’s the question I walked away with... Read more »
There’s been distressing Ebola-related news in recent days. The deadly virus continues to spread in West Africa, with more than 4,500 fatalities now reported, and efforts to halt its spread in the U.S. have been mired in controversy and confusion, forcing... Read more »